Research Article
Serum Fatty Acids, Traditional Risk Factors, and Comorbidity as Related to Myocardial Injury in an Elderly Population with Acute Myocardial Infarction
Table 1
Baseline characteristics of the study cohort. Data presented as percentages or median values (25 and 75 percentiles).
| | Age (y) | 75 (72, 78) | | Gender (male/female) (%) | 73.9/26.1 | | Smoker (current/previous) (%) | 13.7/46.8 | | Body mass index (kg/m2) | 25.6 (23.8, 28.3) | | STEMI (%) | 31.4 | | 3-vessel disease (%) | 21.3 | | Peak Troponin T level (ng/L) @ index MI | 700 (153, 2500) | | NT-proBNP () | 75.0 (33.0, 162.5) | | History of hypertension (%) | 182 (60.9) | | History of hyperlipidemia (%) | 143 (47.8) | | History of atrial fibrillation (%) | 38 (12.7) | | Previous myocardial infarction (%) | 90 (30.1) | | Previous heart failure (%) | 16 (5.4) | | Previous diabetes (%) | 69 (23.1) | | Medication @ index MI (): | | | Aspirin (%) | 64 (47.8) | | Other platelet inhibitors (%) | 7 (5.2) | | Anticoagulation (%) | 19 (14.1) | | Beta blocker (%) | 61 (45.5) | | ACE-I/AT II blocker (%) | 61 (45.5) | | Calcium channel blocker (%) | 30 (22.4) | | Statin (%) | 68 (50.7) | | Diuretic (%) | 38 (28.4) | | Nitrates (%) | 8 (6.0) | | n-3 PUFA supplements (%) () | 135 (45.6) |
|
|
ACE-I/AT II: angiotensin-converting enzyme inhibitors/angiotensin II receptor blockers; STEMI: ST-segment elevation myocardial infarction.
|
